Related by context. All words. (Click for frequent words.) 66 adverse effects 60 Adverse 58 Treatment discontinuations due 57 event reporting Clintrace 57 adversely affect 56 hematologic adverse 56 Discontinuations due 55 unfavorable 54 adverse impacts 54 adversely affecting 53 unanticipated 53 event reporting Empirica 53 Peripheral edema 52 Discontinuations 52 treatment emergent adverse 52 ocular adverse 52 negatively impact 52 hematological adverse 52 cardiovascular thrombotic 51 Operations contained therein 51 Serious ocular 51 uncertainties materialize Shire 51 fluctuations 51 tardive dyskinesia TD 51 severe hypoglycemic 51 uncertainties materialize Shire plc 51 QTc prolongation 51 nonoccurrence 50 elevated plasma concentrations 50 marketconditions 49 thromboembolic 49 adversely impact 49 Treatment emergent adverse 49 adversely affected 49 neuropsychiatric adverse 49 recurrent ischemic 49 neuropsychiatric events 49 events ADEs 49 pyrexia mucositis sepsis febrile 49 fatal anaphylactic 49 Unfavourable 48 incidence ≥ 48 hepatic adverse 48 theimpact 48 adverse reactions 48 neutropenia dehydration dyspnea 48 changesin 48 Serious Adverse Events 48 elevated bilirubin 48 negatively affect 48 impactof 47 hematologic toxicity 47 negative 47 Erythropoietic therapies may 47 detrimental 47 Unfavorable 47 laboratory abnormalities 47 Sepracor anticipates 47 economicconditions 47 neutropaenia 47 anaphylactoid reactions 47 cerebrovascular adverse 47 ischemic cardiovascular 46 nephrotoxicity 46 prolonged QT interval 46 didanosine associated 46 anaphylactoid 46 hypoglycemic events 46 events TEAEs 46 serious cardiovascular thrombotic 46 QT prolongation 46 thrombocytopenia neutropenia 46 related hematological toxicity 46 Febrile neutropenia 46 TNF blocker therapy 46 tumor lysis syndrome 46 dizziness somnolence 46 headache nasopharyngitis 46 gemifloxacin 46 discontinuations due 46 nonhematologic adverse reactions 46 impact 46 Adverse reactions 46 viii 46 TEAEs 46 Skin rashes 46 xxv 46 immunotoxicity 46 recurrent ischemia 46 tenant bankruptcies 46 discontinuations 46 risksassociated 46 hypersensitivity reactions 45 headache arthralgia 45 multivariate adjustment 45 anemia neutropenia 45 nasopharyngitis headache 45 renal toxicity 45 hematological toxicity 45 cardiovascular ischemic 45 lumiracoxib 45 dermatologic toxicities 45 multiple lease terminations 45 postmarketing adverse 45 materially impair 45 non selective NSAIDs 45 thrombotic thrombocytopenic purpura TTP 45 detrimental effect 45 ICD shocks 45 deleterious 45 Exacerbations 45 adrenal suppression 45 severe hypersensitivity reactions 45 cholecystitis 45 postoperative infections 45 CV thrombotic 45 syncopal 45 torsades de pointes 45 iv 45 ARCALYST ® 45 impacts 45 materially adversely affected 45 symptom exacerbation 45 Torsades de Pointes 45 xxii 45 EXJADE 45 acute coronary 45 extrapyramidal side 45 hypersensitivity allergic reactions 45 Discontinuation 45 superficial edema 45 Stent thrombosis 45 affecting 45 neutropenia thrombocytopenia 45 affirmative covenants 45 hematological toxicities 45 neutropenic fever 45 extrapyramidal symptoms 45 QT interval prolongation 44 hemorrhagic cystitis 44 xii 44 nephrotoxic 44 myocardial infarction stroke 44 hepatic dysfunction 44 arterial thromboembolic events 44 materially adversely affect 44 receiving XGEVA 44 adversely 44 Liver toxicity 44 ischemic cerebrovascular 44 optic neuropathy NAION 44 Excluding acquisitions divestitures 44 ovarian hyperstimulation syndrome OHSS 44 hepatotoxicity 44 electrolyte disturbances 44 SeraCare competitors 44 Known hypersensitivity 44 neutropenia anemia 44 cerebrovascular events 44 thromboembolic events 44 exposed horrifically unsanitary 44 unforeseen 44 Airvana anticipates 44 noncardiovascular mortality 44 thrombotic events 44 exacerbation 44 myopathy rhabdomyolysis 44 hypoglycaemic episodes 44 Adverse Events 44 iii 44 Immtech clinical trials 44 injurious 44 Phase III cSSSI 44 favorable 44 events thrombocytopenia neutropenia 44 cerebral ischemic 44 Anaphylactic shock 44 Adverse effects 44 adversely affect NextEra Energy 44 hypercalcemia 44 adversely effecting 44 gastrointestinal toxicities 44 resultsof 44 TYSABRI treated 44 impair 44 unintentional ingestion 43 discontinuation 43 haematologic 43 Secondary endpoints include 43 autoimmune reactions 43 KIF6 carriers 43 render PolyHeme obsolete 43 xxi 43 numbing Hagee 43 nausea dizziness vomiting 43 vii 43 neutropenia 43 effects 43 hyperkalemia 43 GI perforation 43 Bridging developement marine btl 43 hyperprolactinemia 43 adversely impacted 43 thrombocytopenia 43 febrile neutropenia 43 HF hospitalization 43 adverse climatic 43 exfoliative skin 43 Auxilium anticipates 43 oral olanzapine 43 ARCOXIA 43 AEs 43 pulls Darvon painkiller 43 macrovascular disease 43 GEMZAR 43 adverse perinatal 43 fatigue asthenia 43 detrimentally affected 43 concomitant medication 43 strategic pharmacovigilance Empirica 43 ATACAND 43 neuropsychiatric symptoms 43 Protonix ® 43 persistency mortality 43 restriction Depressed 43 arterial thrombotic 43 suboptimal adherence 43 Severe hypersensitivity reactions 43 ventricular arrhythmia 43 poststroke depression 43 multivariable adjustment 43 Drug Administration MedWatch 43 hemorrhagic complications 43 Anturol 43 balsalazide 43 clinically meaningful differences 43 disruptions 43 Hypocalcemia 43 Idenix anticipates 43 patients receiving ERBITUX 43 otherfactors 43 SAEs 43 dysrhythmias 42 somnolence sedation 42 liver transaminases 42 adverse publicity 42 Infusion Reactions Severe 42 bone marrow fibrosis 42 nonfatal MI 42 Hepatotoxicity 42 gastrointestinal ulcers 42 newinformation future 42 unmeasured confounders 42 prepayment speeds loan originations 42 torsemide ER 42 cardiotoxic 42 counterparty creditworthiness 42 affecting Pennichuck Corporation 42 thrombotic cardiovascular 42 Bextra valdecoxib 42 desvenlafaxine succinate 42 PLAVIX ® 42 pancytopenia 42 Severe infusion 42 metabolic acidosis 42 HPA axis suppression 42 headache abdominal pain 42 Silver Wheaton purchases 42 events SAEs 42 asthma flare ups 42 bovine thrombin 42 retrograde ejaculation 42 lymphopenia 42 oral mTOR inhibitor 42 myalgia arthralgia 42 mucosal inflammation 42 xix 42 Retrograde ejaculation 42 depression suicidality 42 strategic pharmacovigilance WebVDME 42 resultof 42 containing abacavir 42 thrombocytopenia anemia 42 hypoglycaemic 42 catastrophic 42 negatively impacting 42 serious Interstitial Lung 42 general economicconditions 42 ACTOplus met XR 42 dermatologic reactions 42 xxviii 42 Adverse events 42 NxStage anticipates 42 apneic 42 parecoxib 42 bleeding ulceration 42 neutropenic patients 42 Insolvency Proceedings 42 xiii 42 gastrointestinal perforation 42 therisk 42 CSLR expectations 42 negatively affected 42 infrequently occurring 42 PDE 5i 42 infusion reactions 42 Neutropenia 42 constipation nausea 42 transaminase elevations 42 concomitant AEDs 42 nasopharyngitis 42 TNF antagonist 42 linaclotide treated 42 impaired cognition 42 APTIVUS r 42 unfavorable cytogenetics 42 leucopenia 42 G6PD deficiency 41 Serious adverse reactions 41 Abrupt withdrawal 41 affect 41 hypoglycemic episodes 41 hepatic failure 41 intracerebral haemorrhage 41 untoward 41 sensory neuropathy 41 atherothrombotic 41 diarrhea nausea vomiting 41 hypobaric hypoxia 41 postoperative AF 41 fulminant hepatitis 41 nonfatal cardiovascular 41 risks associated 41 thrombo embolic 41 hepatic toxicity 41 Tasigna prolongs 41 neutropenic sepsis 41 Hypotension 41 SJS TEN 41 hypocalcemia 41 cSSSIs 41 abrupt discontinuation 41 pulmonary exacerbations 41 angioedema 41 orofacial clefts 41 impacting 41 negatively effected 41 capture exosomes 41 diuretic Cornwell 41 ADCS CGIC 41 neuroleptic malignant syndrome 41 inherent cyclicality 41 ALT flares 41 unseasonal wet 41 delayed gastric emptying 41 adverse cytogenetics 41 pulmonary exacerbation 41 atherosclerotic cardiovascular 41 lactic acidosis 41 toxicities 41 Adverse climatic 41 TRISENOX 41 Rituxan infusion 41 lenalidomide dexamethasone 41 ADEs 41 CIMZIA TM certolizumab pegol 41 Disease ILD 41 QTc intervals 41 Subgroup analyzes 41 gastrointestinal irritation 41 TAXOTERE ® 41 aprepitant 41 Secondary endpoints included 41 syncope fainting 41 INVEGA ® 41 REBETOL therapy 41 Staph aureus infections 41 β blocker 41 Zelnorm Zelmac 41 severe asthma exacerbations 41 otherrisks 41 approvability 41 Starent Networks anticipates 41 irritancy 41 xxvii 41 Pfizer respectfully disagrees 41 nausea constipation 41 oxymorphone ER 41 paliperidone ER 41 xxiv 41 vivo coagulation 41 acid suppressive therapy 41 atypical femur fractures 41 isoproterenol 41 upper gastrointestinal bleeding 41 impair fertility 41 RISPERDAL ® 41 risks associatedwith 41 apnea hypopnea 41 causally related 41 urate lowering 41 Hematologic toxicity 41 pathologic fractures 41 gastrointestinal perforations 41 GI bleeds 41 Serotonin syndrome 41 cardiac valvulopathy 41 InnSuites Hotels 41 symptomatic hyponatremia 41 acquisitions dispositions 41 relapsed MCL 41 anaphylactic reactions 41 Material Adverse Effect 41 ventricular fibrillation VF 41 Bioaccelerate compounds under 41 ourability 41 anemia leukopenia 41 somnolence dizziness 41 unanticipated geological 41 agitation irritability 41 Progressive Multifocal Leukoencephalopathy PML 41 currency fluctuations 41 CFQ R 41 negatively impacted 41 Sucampo Pharmaceuticals anticipates 40 vascular insufficiency 40 esophageal perforation 40 unstable angina pectoris 40 coinfected patients 40 nausea diarrhea 40 occlusive vascular 40 arterial thromboembolic 40 acute ischemic 40 Primary endpoints 40 elevated ALT 40 Gastrointestinal GI 40 CYP #A# 40 chronic pancreatitis CP 40 CVD mortality 40 varicella infection 40 neutropenia febrile neutropenia 40 febrile convulsions 40 dysmenorrhoea 40 elotuzumab 40 renal insufficiency 40 Dyspepsia Tachycardia Myalgia etc. 40 nonaspirin 40 Neuroleptic Malignant Syndrome NMS 40 torsade de pointes 40 xxvi 40 serotonin syndrome 40 behavioral disturbances 40 nonfatal diarrhea 40 symptom flare ups 40 Tardive dyskinesia 40 heterozygous FH 40 linear pharmacokinetics 40 neurocognitive outcomes 40 Xeloda monotherapy 40 interstitial pneumonia 40 surrogate endpoint 40 bone marrow suppression 40 EEG abnormalities 40 mergers consolidations 40 cytopenias 40 p laintiffs 40 Covered Person 40 Preexisting 40 NNT = 40 coinfections 40 hepatitis B infection 40 neurologic sequelae 40 adversely affects 40 naltrexone bupropion 40 mucocutaneous reactions 40 hypokalaemia 40 Syndrome RLS 40 El Boleo Project 40 FERC MPSC NRC 40 fatal myocardial infarction 40 hyponatraemia 40 nonfatal stroke 40 disruption 40 ARLP Partnership 40 thienopyridine 40 pricing pressures 40 CDO financings 40 thereto 40 xi 40 NAbs 40 hematologic toxicities 40 diarrhea dyspepsia 40 limiting toxicity 40 Hematologic 40 TNF alpha antagonists 40 Thrombocytopenia 40 unmeasured confounding 40 nonsignificant 40 supine hypertension 40 cardiac conduction 40 Renal impairment 40 SREs 40 TMP SMX 40 hormone receptor negative 40 SSRI SNRI 40 Adentri 40 VT VF 40 acute phosphate nephropathy 40 preterm newborns 40 intracerebral hemorrhage 40 exacerbations 40 vaccinees 40 teratogenic effects 40 Kaplan Meier estimates 40 pneumonitis 40 polytherapy 40 andgeneral 40 deems immaterial 40 ECG abnormalities 40 non hematological toxicities 40 adversely affect Linktone 40 ix 40 virologic breakthrough 40 bacteriuria 40 dizziness constipation 40 naprosyn 40 hallucinations dyskinesia 40 Shire Attention Deficit 40 levodopa induced 40 adversely effected 40 DSL.net s 40 moderately emetogenic 40 Hepatic Impairment 40 hypoglycaemia 40 cardiac toxicity 40 Ambrilia views 40 COPD exacerbations 40 ii 40 anginal 40 neurologic dysfunction 40 confirmed thrombotic cardiovascular 40 Anaphylactic reactions 40 hematologic abnormalities 40 Mevacor OTC 40 parkinsonian symptoms 40 Aggrastat ® tirofiban hydrochloride 40 β blockers 40 Peripheral neuropathies 40 symptomatic NOH 40 severe 40 PLAVIX R patent 40 salmeterol HFA MDI 40 venous thromboembolic 40 adjudicated cardiovascular 40 Severe allergic reactions 40 SRBD 40 Peptic ulcers 40 achieving PASI 40 impacting WesBanco 40 Acute pancreatitis 40 pulmonary toxicity 40 events AEs 40 cardiac repolarization 40 heparin induced thrombocytopenia 40 NUEDEXTA 40 concomitant medications 40 antiseizure 40 primidone 40 venous thromboembolic disease 40 Vertebral fractures 40 withrespect 40 neurocognitive functioning 40 overdosage 40 SPARLON 40 PDE 5i medications 40 QTc interval 40 tegaserod 40 Thrombotic events 40 RAPTIVA 40 ispinesib administered 40 deterioration 39 corticosteroid therapy 39 postmarketing surveillance 39 fluctuations cyclicality 39 Gastroesophageal Reflux 39 metformin accumulation 39 Crisa acquisition 39 ototoxic 39 Toric ICL 39 FluCAM arm 39 1mg dose 39 dizziness drowsiness 39 peripheral sensory neuropathy 39 sotalol 39 periprocedural 39 ofany 39 retrocessional coverage 39 rheumatoid arthritis HUMIRA 39 clazosentan 39 deleterious effects 39 comorbid psychiatric 39 Acute Radiation Syndrome ARS 39 platelet dysfunction 39 AGGRASTAT ® tirofiban hydrochloride 39 inhaled anticholinergics 39 cyclicality inherent 39 VIOXX Lawsuits 39 Adverse Drug 39 prolactin elevation 39 zileuton IV 39 neurologic outcomes 39 liver decompensation 39 fluid overload 39 inhospital mortality 39 silent ischemia 39 unforseeable 39 ischemic cardiac 39 neurologic complications 39 mania hypomania 39 hepatic insufficiency 39 unforeseen calamities 39 gout flare 39 hypersensitivity reaction 39 contingent guaranties 39 bronchodilatory 39 While Ambrilia anticipates 39 frequent awakenings 39 hyperbilirubinemia 39 Critical limb ischemia 39 pericardial effusion 39 VIIBRYD 39 myelosuppressive chemotherapy 39 inflammatory bowel disorder 39 affecting Amarin 39 Cynosure anticipates 39 results ofoperations 39 aplindore 39 decompensated heart failure 39 alpha interferons 39 Achilles tendon ruptures 39 angioneurotic edema 39 administered erythropoiesis stimulating 39 del 5q MDS 39 severe hypoglycaemia 39 domperidone 39 Acneform rash occurred 39 ofnew 39 Hypersensitivity reactions 39 vi vii 39 glitazone class 39 sinus tachycardia 39 Reye syndrome rare 39 headache flushing 39 Dermatologic toxicities 39 endometrial hyperplasia 39 decompensation 39 peripheral edema 39 recurrent VTE 39 regarding Heska 39 extremity fractures 39 JLG acquisition 39 severe hypoglycemia 39 oral prednisolone 39 phototoxicity 39 suchforward looking 39 venous thromboembolic events 39 Diabetic Mellitus 39 LIFO adjustments 39 impacted negatively 39 atherosclerotic progression 39 Chronic hepatitis C 39 unforeseen occurrences 39 symptomatic paroxysmal AF 39 Osteoporotic fractures 39 venlafaxine ER 39 intravenous bisphosphonates 39 leukopenia 39 ALRI 39 Pruvel 39 teratogenic 39 digoxin toxicity 39 omecamtiv mecarbil 39 dampening effect 39 arthralgia 39 INVEGA ™ 39 unexplained vaginal bleeding 39 KETEK 39 hypercholesterolaemia 39 refractory gout 39 detrimentally affects 39 IMMUNITY FX 39 gastrointestinal GI bleeding 39 Bcr Abl mutations 39 extrapyramidal symptoms EPS 39 thrombotic 39 anaphylactic reactions bronchospasm 39 GSK# [001] 39 Telintra 39 nausea vomiting headache dizziness 39 immune suppressive 39 insomnia somnolence 39 swine fu 39 opioid agonists 39 anaphylaxis angioedema 39 dermal irritation 39 capillary leak 39 EGFRIs 39 akathisia 39 Thomas Sobatam head 39 permitting timelines 39 reactogenicity 39 overlapping toxicities 39 Daytrana TM 39 negatively affecting 39 acetaminophen paracetamol 39 dopaminergic therapy 39 BANZEL 39 macrovascular complications 39 ® Protonix 39 thromboembolism 39 dyspnoea 39 flattening yield curve 39 AVANDIA 39 asthma exacerbation 39 unplanned disruptions 39 dietary deficiency 39 SILENOR ™ 39 spinal cord compression 39 Uncontrolled seizures 39 chromium picolinate supplementation 39 CIPN 39 MAXY alpha 39 attachment garnishment 39 fires Alexis Papachelas 39 unfavorable climatic 39 intracranial hemorrhage ICH 39 TDF FTC 39 Dr.S.Sivaraman shall 39 Zavesca ® 39 NNRTI resistance 39 Observational studies 39 HeFH 39 uncontrolled seizures 39 nausea vomiting constipation 39 gastrointestinal bleeds 39 apneic episodes 39 Favourable 39 severe exacerbations 39 nociceptive pain 39 TOPAMAX ® 39 adversely impacts 39 durable remissions 39 acitretin 39 Lactic acidosis 39 clinicopathological features 39 amenorrhea 39 fluctuation 39 unresectable HCC 39 AC1 CDO 39 AngelCiti expectations 39 coronary revascularization procedures 39 genotypic resistance 39 orotherwise 39 ischemic complications 39 mg XP# 39 diarrhea vomiting nausea 39 azoospermia 39 rhythm disturbances 39 Sensorineural hearing loss 39 headache nausea diarrhea 39 vasodilatory 39 Entereg R 39 oral antidiabetes 39 photosensitivity rash 39 Cardiac arrhythmias 39 expressly disclaimed 39 peginterferon alfa 39 fibrotic disease 39 hypotensive 39 prednisone prednisolone 39 causative pathogen 39 tamoxifen metabolism 39 gonococcal 39 Eloxatin ® 39 serious neuropsychiatric symptoms 39 polymicrobial 39 thrombophlebitis 39 Vitamin D insufficiency 39 Nortel restatements 39 Market Disruption 39 indiplon capsules 39 contingently liable 39 Brian Klimowski meteorologist 39 naronapride 39 chronic urticaria 39 simvastatin ezetimibe 39 oral levofloxacin 39 worsening 39 myelosuppression 39 adversely affect FPL 39 unknown etiology 39 containing LABAs 39 PGP Acquisition 39 sulfite sensitive 39 nonvertebral fracture 39 triglyceride lowering 39 impairment 39 lomitapide 39 UPDRS scores 39 maximal doses 39 symptomatic hypotension 39 reasonably foreseeable 39 artery thickening 39 impacted adversely 39 risks anduncertainties 39 cutaneous lupus 39 mitral insufficiency 39 Prosaptide 39 uncertaintiesthat 39 molted skins clinging 39 sodium valproate 39 xxxii 39 causes myocardial ischemic 39 elevated IOP 39 prolonged cytopenias 38 PegIFN RBV 38 Vaccine Adverse Event 38 impaired renal 38 vasogenic edema 38 EMEND 38 recurrent DVT 38 fetal malformations 38 interferon gamma 1b 38 REMICADE ® 38 histrelin manufacturing marketing 38 collateralization tests 38 threatening ventricular arrhythmias 38 Sleep disturbances 38 Drospirenone 38 INTEGRILIN 38 postoperative bleeding 38 Fibrillex TM 38 headache nausea fatigue 38 AGGRASTAT R tirofiban hydrochloride 38 severely impacted 38 lacosamide 38 acneform rash 38 xiv 38 Shire plc Attention Deficit 38 thereby negatively impacting 38 thorough QT 38 concomitant cardiac 38 Magnesium deficiency 38 haemorrhagic stroke 38 infants Sundlof 38 untreated OSA 38 resuscitated cardiac arrest 38 EFFEXOR XR 38 cerebral ischemia 38 thrombotic thromboembolic complications 38 cSSSI 38 recurrent venous thromboembolism 38 antiepileptic 38 Oral mucositis 38 Postmarketing 38 abacavir hypersensitivity 38 sulfite allergies 38 TMJD 38 pharmacodynamic parameters 38 cerebrovascular accidents 38 angiogenic therapy 38 paresthesias 38 IgE mediated 38 thrombosis blood clots 38 embolic stroke 38 pemoline 38 revise anyforward looking 38 brown pelicans sea turtles 38 chemically derived 38 rhythm abnormalities 38 panitumumab Vectibix 38 hypomagnesemia 38 Heavy snorers 38 receiving ISENTRESS 38 radiation dermatitis 38 undue prejudice 38 DETROL LA 38 unmeasured factors 38 pamidronate 38 geological metallurgical 38 GIK infusion 38 Ticagrelor 38 Quetiapine 38 AML MDS 38 severe anaphylactic reaction 38 formoterol LABA 38 DailyFX provides forex 38 venlafaxine XR 38 ACIPHEX 38 light headedness dizziness 38 Elecsys Corporation SEC 38 potassium sparing diuretics 38 Irinotecan Hydrochloride Injection 38 macroburst Ciemnecki 38 pulmonary infiltrates 38 neck receiving ERBITUX 38 heterosexual male circumcision 38 amortizable intangible assets 38 covenant defaults 38 BEXXAR Therapeutic Regimen 38 nasal polyposis 38 NNL failure 38 concomitant 38 APTIVUS ritonavir 38 mediated inflammatory 38 malignancy HCM 38 clinically asymptomatic 38 interstitial lung disease 38 hypopituitarism 38 hypersomnia 38 jaw osteonecrosis 38 unfavorable variances 38 ddI 38 hypercholesterolemic patients 38 chronic idiopathic thrombocytopenic purpura 38 GISSI HF 38 divalproex 38 DLTs 38 Premature menopause 38 symptomatic pulmonary embolism 38 conjugated equine estrogen 38 oxycodone CR 38 experienced hypomagnesemia 38 external genital lesions 38 Zyprexa LAI 38 currency fluctuation 38 arbaclofen 38 Testosterone deficiency 38 stent thrombosis blood clots 38 erythema redness 38 diarrhea headache nausea 38 Auxilium assessments 38 beta carotene supplementation 38 RISPERDAL 38 Boron disrupts nuclear 38 Defendants misrepresented 38 variability 38 O PPDS 38 Allergic reactions 38 factors APPY 38 arising therefrom 38 potentially hepatotoxic 38 NEUMUNE 38 KRAS mutant tumors 38 Suicidal ideation 38 postoperative ileus POI 38 reduced workforces scarcity 38 inflammatory biomarkers 38 mucositis 38 vernakalant oral 38 sideeffects 38 Iron deficiency anemia 38 stroke myocardial infarction 38 residual confounding 38 chemotherapy induced neutropenia 38 threatening anaphylactic shock 38 benazepril 38 Dextofisopam 38 Carotid endarterectomy 38 apositive 38 impacton 38 Gastrointestinal GI perforation 38 antiseizure medications 38 macrovascular 38 Kidney toxicity nephrotoxicity 38 statistically significant 38 HMG CoA reductase inhibitors 38 cerebral vasospasm 38 Liefferink 38 commonly thrombocytopenia 38 serologically active patients 38 delayed CINV 38 INTEGRILIN ® 38 nocturnal hypoglycaemia 38 prejudicial 38 MEVACOR 38 receiving VELCADE 38 warfarin erythromycin 38 electrolyte abnormalities 38 Reglan metoclopramide 38 Serious Adverse Event 38 hypoglycemia 38 inhaled tobramycin 38 xvii 38 ALTACE 38 Secondary endpoints 38 postprocedure 38 repercussion 38 tapentadol ER